Perspectives
Nature Reviews Cancer 8, 705-713 (September 2008) | doi:10.1038/nrc2468
Article series: Hypoxia and metabolism
Opinion: Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko1 About the author
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Author affiliations
-
Nicholas C. Denko is at the division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA.
Email: nicholas.denko@stanford.edu
Published online 14 August 2008
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
HIF, a missing link between metabolism and cancerNature Medicine News and Views (01 Oct 2005)
Immunology Oxygen and the inflammatory cellNature News and Views (17 Apr 2003)
See all 5 matches for News And ViewsRESEARCH
The structure of Desulfovibrio vulgaris rubrerythrin reveals a unique combination of rubredoxin-like FeS 4 and ferritin-like diiron domainsNature Structural Biology Article (01 Jun 1996)
Toward fluorescence nanoscopyNature Biotechnology Research (01 Nov 2003)
See all 37 matches for Research